A 61-year-old African American male with history of uncontrolled Type 2 diabetes mellitus, hypertension, anxiety, major depressive…
Improved glycemia within the first two or three days of hospitalization is a better predictor of outcomes…
Diabetes, heart disease and long-term lung problems are the most common underlying conditions among Americans hospitalized with…
The U.S. Food and Drug Administration has approved Baqsimi nasal powder, the first glucagon therapy approved for…
A growing number of younger U.S. adults are being hospitalized for stroke, and a new study suggests…
Intranasal glucagon is emerging as a promising alternative to intramuscular glucagon as a rescue treatment for hypoglycemia…
BOSTON—Diabetic ketoacidosis (DKA) literally hits home for Chandra Aubin, MD, associate professor of Washington University School of…
Don’t assume that the rapid-fire session on diabetic ketoacidosis (DKA) titled “DKA and Hyperosmolar Syndrome—High-Yield Pearls and…
Although a fully automated solution to the challenge of insulin regulation in patients with diabetes is still…
Representative Raul Ruiz, MD, MPH, a former ED physician, steps up to aid a sick airline passenger…